Microwave produced 8-methyl-1,2,4,8-tetraazaspiro[4.5]dec-2-en-3-amine derivatives : their in vitro and in silico analysis

© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG..

Compound 1 is formed by a microwave-assisted multicomponent reaction of 1-methylpiperidin-4-one, 2-amino-4-methoxy-6-methyl-1,3,5-triazine, and thiosemicarbazide, followed by the synthesis of Schiff base 2a-l with a variety of aldehydes. A comparison was made between the conventional and microwave methods, and the microwave approach was shown to be considerably superior to the classical method since it takes less time and produces higher yields. Several spectral investigations, including 1H NMR, 13C NMR, Mass, and IR spectroscopy, are used to characterize the complete series. In vitro antibacterial testing suggests that compounds 2c, 2f, and 2g are promising antibacterial agents, although compounds 2d, 2e, and 2l are effective antimycobacterial agents when compared to the conventional medicine Rifampicin. The docking score from docking studies is considerable, which validates the results of the biological examination. Molecular docking was performed on Escherichia coli DNA gyrase. According to the in silico ADME analysis, each drug molecule is ideal for use in terms of drug solubility, hydrogen bonding, and cell permeability.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - year:2023

Enthalten in:

Molecular diversity - (2023) vom: 06. Juni

Sprache:

Englisch

Beteiligte Personen:

Patel, Parth P [VerfasserIn]
Patel, Navin B [VerfasserIn]
Tople, Manesh S [VerfasserIn]
Patel, Vatsal M [VerfasserIn]
Ahmed, Iqrar [VerfasserIn]
Patel, Harun [VerfasserIn]

Links:

Volltext

Themen:

ADME study
Antimicrobial
Antitubercular
Journal Article
Microwave synthesis
Molecular docking

Anmerkungen:

Date Revised 08.06.2023

published: Print-Electronic

Citation Status Publisher

doi:

10.1007/s11030-023-10665-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357822781